Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.63%
1,044.40
-6.67
-0.63%
—1,051.071,046.551,057.891,042.67——
SIXC
Communications
SIXC
Communications
SIXC
-2.37%
569.41
-13.84
-2.37%
—583.25583.25583.25568.79——
SIXE
Energy
SIXE
Energy
SIXE
+1.59%
1,295.51
+20.30
+1.59%
—1,275.211,277.701,302.121,275.67——
SIXI
Industrials
SIXI
Industrials
SIXI
-2.32%
1,627.51
-38.60
-2.32%
—1,666.111,658.231,661.311,625.88——
SIXM
Financials
SIXM
Financials
SIXM
-0.57%
605.38
-3.48
-0.57%
—608.86607.95610.78603.35——
SIXR
Staples
SIXR
Staples
SIXR
-0.44%
821.48
-3.65
-0.44%
—825.13825.12832.42820.53——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.05%
198.39
+0.090
+0.05%
—198.30198.30199.82197.25——
SIXT
Technology
SIXT
Technology
SIXT
-3.14%
2,669.58
-86.42
-3.14%
—2,756.002,727.872,729.882,668.52——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.23%
919.05
+2.10
+0.23%
—916.95917.31921.78912.88——
SIXV
Health care
SIXV
Health care
SIXV
-0.34%
1,474.76
-4.99
-0.34%
—1,479.751,478.541,486.621,473.75——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.75%
2,200.00
-39.08
-1.75%
—2,239.082,228.382,241.812,198.75——
RO:SWX
Roche Holding AG
CHF 321.00
0.00%
(0.00) 1D
Mar 26, 5:31:28 PM GMT+1  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for RO...
Mkt. cap
254.25B
Avg. vol.
41.48K
Volume
0.00
Dividend
3.05%
Quarterly dividend
CHF 2.45
Ex dividend date
Mar 27, 2025
P/E ratio
20.01
52-wk high
CHF 383.00
52-wk low
CHF 244.00
EPS
CHF 16.04
Shares outstanding
106.69M
No. of employees
113K
News stories
From sources across the web
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG
CEOThomas Schinecker
Employees113K
FoundedOct 1, 1896
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websiteroche.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
15.92B
15.92B
15.75B
15.75B
Cost of goods sold
3.87B
3.87B
4.21B
4.21B
Cost of revenue
3.87B
3.87B
4.21B
4.21B
Research and development expenses
3.11B
3.11B
3.15B
3.15B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.29B
3.29B
3.59B
3.59B
Operating expense
6.30B
6.30B
6.82B
6.82B
Total operating expenses
10.17B
10.17B
11.03B
11.03B
Operating income
5.75B
5.75B
4.72B
4.72B
Other non operating income
4.00M
4.00M
-1.50M
-1.50M
EBT including unusual items
4.79B
4.79B
3.69B
3.69B
EBT excluding unusual items
5.46B
5.46B
4.37B
4.37B
Income tax expense
878.00M
878.00M
709.00M
709.00M
Effective tax rate
18.31%
18.31%
19.20%
19.20%
Other operating expenses
-110.50M
-110.50M
77.50M
77.50M
Net income
3.70B
3.70B
2.74B
2.74B
Net profit margin
23.27%
23.27%
17.36%
17.36%
Earnings per share
-
-
-
-
Interest and investment income
56.50M
56.50M
45.00M
45.00M
Interest expense
-304.00M
-304.00M
-289.50M
-289.50M
Net interest expenses
-247.50M
-247.50M
-244.50M
-244.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
6.53B
6.53B
5.50B
5.50B
Gain or loss from assets sale
-
-
-21.50M
-21.50M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer